A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis

Andrew Schrepf, Chelsea M Kaplan, Eric Ichesco, Tony Larkin, Steven E Harte, Richard E Harris, Alison D Murray, Gordon D Waiter, Daniel J Clauw, Neil Basu, Andrew Schrepf, Chelsea M Kaplan, Eric Ichesco, Tony Larkin, Steven E Harte, Richard E Harris, Alison D Murray, Gordon D Waiter, Daniel J Clauw, Neil Basu

Abstract

It is unknown how chronic inflammation impacts the brain. Here, we examined whether higher levels of peripheral inflammation were associated with brain connectivity and structure in 54 rheumatoid arthritis patients using functional and structural MRI. We show that higher levels of inflammation are associated with more positive connections between the inferior parietal lobule (IPL), medial prefrontal cortex, and multiple brain networks, as well as reduced IPL grey matter, and that these patterns of connectivity predicted fatigue, pain and cognitive dysfunction. At a second scan 6 months later, some of the same patterns of connectivity were again associated with higher peripheral inflammation. A graph theoretical analysis of whole-brain functional connectivity revealed a pattern of connections spanning 49 regions, including the IPL and medial frontal cortex, that are associated with peripheral inflammation. These regions may play a critical role in transducing peripheral inflammatory signals to the central changes seen in rheumatoid arthritis.

Conflict of interest statement

Pfizer provided supplementary funding to N.B. for data acquisition. D.J.C. has consulted or served as an expert witness for Forest Laboratories, Pfizer, Inc, Cerephex Corp, Eli Lilly and Company, Merck & Co, Nuvo Research Inc, Tonix Pharmaceuticals, Johnson & Johnson, Pierre Fabre, Cypress Biosciences, Wyeth Pharmaceuticals, UCB, AstraZeneca, Jazz Pharmaceuticals, Abbott Laboratories, and Iroko Pharmaceuticals. R.E.H. has consulted for Pfizer, Inc. S.E.H. has received research funding from Aptinyx, Cerephex, Eli Lily, Forest Laboratories, and Merck and served as a consultant for Pfizer, Analgesic Solutions, Aptinyx, and deCode Genetics. A.S., C.M.K., S.E.H., R.E.H., T.L., E.I., and D.J.C. have all received funding from the National Institutes of Health. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Box plots of clinical characteristics and symptoms at baseline and 6 months for 54 rheumatoid arthritis patients. The center line represents the median value, the lower bound of the box represents the 25th percentile, the upper bound of the box the 75th percentile, and the whiskers represent minimum and maximum values, or 1.5 times the interquartile range in the presence of outliers, which are indicated by dots or asterisks
Fig. 2
Fig. 2
Inflammation-associated functional connectivity patterns. Brain regions (medial prefrontal cortex [mPFC], inferior parietal lobule [IPL]) showing positive connections to the default mode network (DMN; a), dorsal attention network (DAN; b, c), medial visual network (MVN; d), and salience network (SLN; e, f) at higher levels of peripheral inflammation. Scatterplots showing the strength connectivity and levels of erythrocyte sedimentation rate (ESR) are displayed below brain images. All associations were detected using seed networks identified by independent component analysis in a whole-brain search with ESR as the primary predictor of interest controlling for age and sex with p < 0.05 false discovery rate (FDR) cluster corrected for multiple comparisons
Fig. 3
Fig. 3
Overlap of inflammation-associated functional connectivity changes. a Brain regions (medial prefrontal cortex [mPFC], inferior parietal lobule [IPL]) showing positive connectivity to the different networks (medial visual network [MVN], default mode network [DMN], dorsal attention network [DAN], salience network [SLN]) at higher levels of peripheral inflammation measured by erythrocyte sedimentation rate (ESR). Area of reduced grey matter volume is shown in light blue. This was identified by testing the association of ESR with grey matter volume derived through voxel-based morphometry (VBM) in 8 mm spheres extracted around the significant peak cluster coordinates from the session 1 network to whole-brain connectivity analyses, in multiple linear regression analyses controlling for age and sex at p < 0.05 uncorrected. b Scatterplot showing the association between ESR and grey matter volume. Displayed at p = 0.005 voxel threshold corrected for age and sex
Fig. 4
Fig. 4
Overlap of inflammation-associated functional connectivity at both time points. a Positive connections between the default mode network (DMN) with the inferior parietal lobule (IPL), b dorsal attention network (DAN) and IPL, c the DAN and medial prefrontal cortex (mPFC) at baseline and 6 months that were associated with increased peripheral inflammation measured by erythrocyte sedimentation rate (ESR). Scatterplots showing the association between ESR and the strength of connectivity are displayed next to each brain region. Extracted average Fisher r values from 8 mm spheres derived from the significant peak cluster coordinates identified at session 1 (baseline) were used at session 2 (month 6) and these were correlated with concurrent ESR values using Pearson correlations at p < 0.05 uncorrected. Baseline regions are shown in orange, 6 months in blue. Displayed at p = 0.005 voxel threshold
Fig. 5
Fig. 5
Summary of inflammation-associated functional connectivity changes. a Nodes and edges showing the Network-Based Statistic (NBS) inflammation configuration, with scatterplot showing the association (Pearson correlation) between erythrocyte sedimentation rate (ESR) and the average strength of connectivity across the 54 edges. Undirected and weighted Fisher z-transformed bivariate correlation matrices of connectivity were created for each subject from 10 mm diameter spheres at the 264 nodes of the Power atlas (264 × 264 matrices). Identified nodes and edges associated in aggregate with higher ESR are derived from permutation testing at family wise error corrected p < 0.05. b Overlap of regions of positive connectivity identified through seed network to whole-brain analyses and nodes identified through NBS analyses of higher inflammation

References

    1. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46–56. doi: 10.1038/nrn2297.
    1. Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am. J. Epidemiol. 2003;158:844–851. doi: 10.1093/aje/kwg222.
    1. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334. doi: 10.1001/jama.286.3.327.
    1. Siemes C, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol. 2006;24:5216–5222. doi: 10.1200/JCO.2006.07.1381.
    1. Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev. Chronic Dis. 2005;2:A14.
    1. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 2007;7:429–442. doi: 10.1038/nri2094.
    1. Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 2010;24:558–563. doi: 10.1016/j.bbi.2009.12.009.
    1. Harrison NA, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry. 2009;66:407–414. doi: 10.1016/j.biopsych.2009.03.015.
    1. Capuron L, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–652. doi: 10.1016/S0893-133X(01)00407-9.
    1. Prevoo ML, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–48. doi: 10.1002/art.1780380107.
    1. Beckmann CF, DeLuca M, Devlin JT, Smith SM. Investigations into resting-state connectivity using independent component analysis. Philos. Trans. R. Soc. B. 2005;360:1001–1013. doi: 10.1098/rstb.2005.1634.
    1. Power JD, et al. Functional network organization of the human brain. Neuron. 2011;72:665–678. doi: 10.1016/j.neuron.2011.09.006.
    1. Zalesky A, Fornito A, Bullmore ET. Network-based statistic: identifying differences in brain networks. Neuroimage. 2010;53:1197–1207. doi: 10.1016/j.neuroimage.2010.06.041.
    1. Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009;10:186–198. doi: 10.1038/nrn2575.
    1. van den Heuvel MP, Sporns O. Network hubs in the human brain. Trends Cogn. Sci. 2013;17:683–696. doi: 10.1016/j.tics.2013.09.012.
    1. Wells G, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann. Rheum. Dis. 2009;68:954–960. doi: 10.1136/ard.2007.084459.
    1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011;365:2205–2219. doi: 10.1056/NEJMra1004965.
    1. Hess A, et al. Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc. Natl. Acad. Sci. USA. 2011;108:3731–3736. doi: 10.1073/pnas.1011774108.
    1. Nikolaus S, Bode C, Taal E, de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. 2013;65:1128–1146. doi: 10.1002/acr.21949.
    1. Harrison NA, Cercignani M, Voon V, Critchley HD. Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology. 2015;40:831–838. doi: 10.1038/npp.2014.222.
    1. Benson S, et al. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain. 2012;153:794–799. doi: 10.1016/j.pain.2011.12.001.
    1. Kullmann JS, et al. Experimental human endotoxemia enhances brain activity during social cognition. Soc. Cogn. Affect. Neurosci. 2014;9:786–793. doi: 10.1093/scan/nst049.
    1. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage. 2009;47:881–890. doi: 10.1016/j.neuroimage.2009.04.040.
    1. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual. Life Outcomes. 2009;7:25. doi: 10.1186/1477-7525-7-25.
    1. Labrenz F, et al. Alterations in functional connectivity of resting state networks during experimental endotoxemia–an exploratory study in healthy men. Brain Behav. Immun. 2016;54:17–26. doi: 10.1016/j.bbi.2015.11.010.
    1. Vatansever D, Menon DK, Manktelow AE, Sahakian BJ, Stamatakis EA. Default mode network connectivity during task execution. Neuroimage. 2015;122:96–104. doi: 10.1016/j.neuroimage.2015.07.053.
    1. Vatansever D, Menon DK, Manktelow AE, Sahakian BJ, Stamatakis EA. Default mode dynamics for global functional integration. J. Neurosci. 2015;35:15254–15262. doi: 10.1523/JNEUROSCI.2135-15.2015.
    1. Reuter-Lorenz PA, Cappell KA. Neurocognitive aging and the compensation hypothesis. Curr. Dir. Psychol. Sci. 2008;17:177–182. doi: 10.1111/j.1467-8721.2008.00570.x.
    1. Wallin K, et al. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J. Alzheimers Dis. 2012;31:669–676. doi: 10.3233/JAD-2012-111736.
    1. Chou RC, Kane M, Ghimire S, Gautam S, Gui J. Treatment for rheumatoid arthritis and risk of Alzheimer’s disease: a nested case-control analysis. CNS Drugs. 2016;30:1111–1120. doi: 10.1007/s40263-016-0374-z.
    1. Guo CC, et al. Network-selective vulnerability of the human cerebellum to Alzheimer’s disease and frontotemporal dementia. Brain. 2016;139:1527–1538. doi: 10.1093/brain/aww003.
    1. Jacobs HIL, et al. The cerebellum in Alzheimer’s disease: evaluating its role in cognitive decline. Brain. 2018;141:37–47. doi: 10.1093/brain/awx194.
    1. Loggia ML, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138:604–615. doi: 10.1093/brain/awu377.
    1. Hillmer AT, et al. Microglial depletion and activation: a [(11)C]PBR28 PET study in nonhuman primates. EJNMMI Res. 2017;7:59. doi: 10.1186/s13550-017-0305-0.
    1. Kreisl WC, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain. 2013;136:2228–2238. doi: 10.1093/brain/awt145.
    1. Aletaha D, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581. doi: 10.1002/art.27584.
    1. Chalder T, et al. Development of a fatigue scale. J. Psychosom. Res. 1993;37:147–153. doi: 10.1016/0022-3999(93)90081-P.
    1. Yarkoni T. Big correlations in little studies: inflated fMRI correlations reflect low statistical power-commentary on Vul et al. (2009) Perspect. Psychol. Sci. 2009;4:294–298. doi: 10.1111/j.1745-6924.2009.01127.x.
    1. Wolfe F, Pincus T. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness. J. Rheumatol. 2001;28:1817–1824.
    1. Wang W, et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 2012;32:887–893. doi: 10.1007/s00296-010-1710-0.
    1. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Investig. 2008;118:3537–3545. doi: 10.1172/JCI36389.
    1. Sharma R, et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 2000;36:523–528. doi: 10.1016/S0735-1097(00)00745-2.
    1. Hardy R, et al. Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann. Rheum. Dis. 2008;67:1204–1210. doi: 10.1136/ard.2008.090662.
    1. Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1:653–657. doi: 10.1016/S0140-6736(81)91565-8.
    1. Wolfe F, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 2011;38:1113–1122. doi: 10.3899/jrheum.100594.
    1. Cook DB, O’Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage. 2007;36:108–122. doi: 10.1016/j.neuroimage.2007.02.033.
    1. Basu N, et al. Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology (Oxf.) 2014;53:2080–2087. doi: 10.1093/rheumatology/keu243.
    1. Cole MW, Bassett DS, Power JD, Braver TS, Petersen SE. Intrinsic and task-evoked network architectures of the human brain. Neuron. 2014;83:238–251. doi: 10.1016/j.neuron.2014.05.014.
    1. Calhoun VD, Adali T, Pekar JJ. A method for comparing group fMRI data using independent component analysis: application to visual, motor and visuomotor tasks. Magn. Reson. Imaging. 2004;22:1181–1191. doi: 10.1016/j.mri.2004.09.004.
    1. Smith SM, et al. Correspondence of the brain’s functional architecture during activation and rest. Proc. Natl. Acad. Sci. USA. 2009;106:13040–13045. doi: 10.1073/pnas.0905267106.
    1. Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–141. doi: 10.1089/brain.2012.0073.
    1. Birn RM, et al. The effect of scan length on the reliability of resting-state fMRI connectivity estimates. Neuroimage. 2013;83:550–558. doi: 10.1016/j.neuroimage.2013.05.099.
    1. Poldrack RA. Region of interest analysis for fMRI. Soc. Cogn. Affect. Neurosci. 2007;2:67–70. doi: 10.1093/scan/nsm006.
    1. Cohen AL, et al. Defining functional areas in individual human brains using resting functional connectivity MRI. Neuroimage. 2008;41:45–57. doi: 10.1016/j.neuroimage.2008.01.066.
    1. Cole MW, et al. Multi-task connectivity reveals flexible hubs for adaptive task control. Nat. Neurosci. 2013;16:1348–1355. doi: 10.1038/nn.3470.
    1. Dosenbach NU, et al. Distinct brain networks for adaptive and stable task control in humans. Proc. Natl. Acad. Sci. USA. 2007;104:11073–11078. doi: 10.1073/pnas.0704320104.
    1. Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage. 2010;52:1059–1069. doi: 10.1016/j.neuroimage.2009.10.003.
    1. Sporns O, Honey CJ, Kotter R. Identification and classification of hubs in brain networks. PLoS ONE. 2007;2:e1049. doi: 10.1371/journal.pone.0001049.
    1. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95–113. doi: 10.1016/j.neuroimage.2007.07.007.

Source: PubMed

3
購読する